Daniel's story was simple.
Rosental Pharmaceuticals developed a new weight-loss drug, LCD. They partnered with the government, which purchased the drug in bulk and distributed it free of charge to individuals well below retirement age who, due to obesity, had lost their ability to work and relied on welfare. The aim was to help these individuals overcome the physical and mental health issues caused by obesity, enabling them to regain their ability to work, find employment, and reintegrate into society.
Before full implementation, the program was piloted in several communities, including the one where the Hill family lived. Daniel, weighing over 350 pounds, received the new weight-loss drug from a community worker.
Daniel was happy. He was a conscientious young man who wanted to change h
